Do Different Lyme Strains Affect Treatment Outcomes?
Not all Lyme disease infections are the same. Differences in Borrelia burgdorferi strains may help explain why some patients experience more severe illness—or do not respond as expected to treatment. :contentReference[oaicite:0]{index=0}
Strain Differences and Virulence
Researchers have identified multiple genetic variants of Borrelia burgdorferi, each expressing a different outer surface protein (OspC).
These differences appear to influence how the bacteria behave in the body.
Some strains:
- Rarely cause human disease
- Remain localized at the site of a tick bite
- Are more likely to spread throughout the body (systemic infection)
This variation may help explain differences in symptom severity among patients.
Multiple Strains from a Single Tick Bite
Advanced genetic studies have shown that ticks often carry more than one strain of Borrelia burgdorferi.
In one study, 70% of infected ticks carried multiple strains.
This means a single tick bite may expose a patient to several strains at once.
Mixed infections may result in more complex disease patterns.
Why This Matters Clinically
Different strains may interact with the immune system in different ways.
Some strains are more likely to disseminate, while others may trigger stronger inflammatory responses.
When multiple strains are present, the interaction between them may influence:
- Severity of illness
- Symptom patterns
- Response to treatment
An Evolving Pathogen
Researchers have also observed that Borrelia burgdorferi continues to evolve in response to host immune defenses.
This ongoing genetic diversity may contribute to variability in clinical presentation and outcomes.
Clinical Perspective
The diversity of Lyme disease strains highlights the complexity of diagnosis and treatment.
While standard antibiotic regimens are effective for many patients, variability in strain behavior may help explain why outcomes differ.
Further research is needed to better understand how strain diversity influences treatment response.
Patients may benefit from understanding persistent symptoms, reviewing testing limitations, and considering coinfections when symptoms are prolonged.
References
- Walter KS et al. PLoS Pathog. 2016.
- Seinost G et al. Infect Immun. 1999.
- Wormser GP et al. J Infect Dis. 1999.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
